Drugs / BALI association
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05542173 | Sep 2024 → Sep 2025 | aphthous stomatitis | EMS | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BALI association | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05542173 ↗ |
| Route | Oral | “BALI association oral suspension, 25 mg + 25 mg + 15 mg, oral.” NCT05542173 ↗ |